In the Lab By Sharon Begley Dust off the crystal ball: It’s time for STAT’s 2020 Nobel Prize predictions
In the Lab By Sharon Begley and Elizabeth Cooney Two female CRISPR scientists make history, winning Nobel Prize in chemistry for genome-editing discovery
In the Lab By Elizabeth Cooney ‘A terrific choice’: George Church salutes fellow CRISPR pioneers’ historic Nobel win
First Opinion By Josiah Zayner CRISPR babies scientist He Jiankui should not be villainized — or headed to prison
In the Lab By Sharon Begley Who gets credit for CRISPR? Prestigious award singles out three, and leaves out a notable scientist
Biotech By Andrew Joseph Patent board delivers blow to University of California over its CRISPR invention claims
Biotech By Adam Feuerstein CRISPR Therapeutics’ CAR-T treatment shows encouraging results, but one death is tied to therapy
First Opinion By Patrick Skerrett The CRISPR Nobel was about more than two women scientists. It was about all of them
In the Lab By Andrew Joseph The CRISPR story: How a basic research discovery changed science and led to a Nobel
Health By Matthew Herper Jennifer Doudna, now a Nobel winner, on CRISPR and its role in medical research
First Opinion By Josephine Johnston The U.S. must do some heavy lifting to prepare for heritable genome editing
Health By Andrew Joseph Expert panel lays out guidelines for germline editing, while warning against pursuit of ‘CRISPR babies’
In the Lab By Sharon Begley Gene-editing discovery could point the way toward a ‘holy grail’: cures for mitochondrial diseases
In the Lab By Sharon Begley In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys
Biotech By Jonathan Saltzman — Boston Globe Verve, raising another $63 million, seeks to advance gene-editing treatment for heart disease
Biotech By Sharon Begley Deluge of genome editing therapies ends research drought for sickle cell disease
Health By Sharon Begley New CRISPR-based test for Covid-19 could be a simple, cheap at-home diagnostic, scientists say
Health By Rebecca Robbins, Damian Garde, and Adam Feuerstein ‘Science is very much a part of culture’: Siddhartha Mukherjee dives into the history of genetics in a new Ken Burns film
First Opinion By Neal Baer Covid-19 is scary. Could a rogue scientist use CRISPR to conjure another pandemic?
In the Lab By Associated Press In its first use inside the human body, CRISPR genome editing tested as blindness therapy
In the Lab By Sharon Begley DNA sleuths read the coronavirus genome, tracing its origins and looking for dangerous mutations
The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein Listen: Biohacker Josiah Zayner on getting canceled, good news in cancer, and a long road in Ebola
First Opinion By Josephine Johnston He Jiankui is going to jail. Would the U.S. criminally prosecute a rogue gene-editing researcher?
Don't Miss By STAT staff What will 2020 bring for medicine and science? We asked 16 leaders for predictions
In the Lab By Sharon Begley Creating Pig3.0, the world’s most CRISPR’d animal, raises hopes of transplantable organs
Biotech By Sharon Begley and Adam Feuerstein First CRISPR treatment for blood diseases shows early benefits in two patients
In the Lab By Sharon Begley You had questions for David Liu about CRISPR, prime editing, and advice to young scientists. He has answers